The Mouse Models of Human Cancers Consortium is a trans-disciplinary program, which focuses on the translational uses of genetically engineered mouse cancer models and other related mouse genetic resources. The initial goal of the program was to stimulate the integration of mouse models into cancer research. Subsequently, the National Cancer Institute (NCI) incorporated increased translational science goals for research-focused awards and modified the Consortium management structure to encourage more science leadership awards. This evaluation quantified the outcomes that would be appropriate for future evaluations of the program.
Evaluators concluded that an outcome evaluation was feasible and warranted. They provided an evaluation plan with an integrated study with two stages: First, that NCI conduct a process evaluation to identify successes and opportunities for mid-course correction regarding Consortium activities and organization; second, that NCI conduct an outcome evaluation near the end of the current award period to capture the scientific impact of the modified Consortium management structure.
Report Title: Mouse Models of Human Cancer Consortium Feasibility Study: Final Report
Agency Sponsor: NIH, National Institutes of Health
Federal Contact: Rosanna Ng, 301-496-5367
Performer: IDA Science and Technology Policy Institute (STPI)
Record ID: 9826 (Report issued August 26, 2011)